Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) in patients with mild to moderate Alzheimer's Disease who are Apolopoprotien E4 epsilon4 Carriers
Jicha, Gregory
(PI)
Cambi, Franca
(CoI)
Cooper, Gregory
(CoI)
Fee, Dominic
(CoI)
Markesbery, William
(CoI)
Schmitt, Frederick
(CoI)
Smith, Charles
(CoI)
Sanders-Brown Center on Aging (SBCoA)
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
7/1/08
→
11/30/10
Funding
Elan Pharmaceuticals PLC:
$128,300.00
View all
View less